🇺🇸 FDA

Intelligence Platform

Patents

Browse 26 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12343342

Methods for treating soft tissue sarcoma

Lixte Biotechnology, Inc. · Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931354

Formulations of oxabicycloheptanes and oxabicycloheptenes

Lixte Biotechnology, Inc. · Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11866444

Oxabicycloheptane prodrugs

Lixte Biotechnology, Inc. · Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11236102

Oxabicycloheptane prodrugs

Lixte Biotechnology, Inc. · Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668062

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

Lixte Biotechnology, Inc. · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10618908

Oxabicycloheptane prodrugs

Lixte Biotechnology, Inc. · Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10532050

Formulations of oxabicycloheptanes and oxabicycloheptenes

Lixte Biotechnology, Inc. · Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10434100

Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes

Lixte Biotechnology, Inc. · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10413541

Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disor

Lixte Biotechnology, Inc. · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10399993

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10364252

Oxabicycloheptane prodrugs

Lixte Biotechnology, Inc. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149847

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

Lixte Biotechnology, Inc. · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10023587

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9994584

Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-ca

Lixte Biotechnology, Inc. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9988394

Oxabicycloheptane prodrugs

Lixte Biotechnology, Inc. · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833450

Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disor

Lixte Biotechnology, Inc. · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9079917

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822461

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541458

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8455688

HDAC inhibitors

Lixte Biotechnology, Inc. · Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8426444

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329719

Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

Lixte Biotechnology, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227473

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

Lixte Biotechnology, Inc. · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143445

HDAC inhibitors

Lixte Biotechnology, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted